185 related articles for article (PubMed ID: 38127240)
21. Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Velarde-Salcedo R; Pérez-González LF; Rodríguez-Báez AS; Arriaga-García FJ; Milán-Segovia RDC; Romano-Moreno S; Medellín-Garibay SE
Eur J Pediatr; 2023 Sep; 182(9):4143-4152. PubMed ID: 37436522
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis.
Chen CY; Xie M; Gong J; Yu N; Wei R; Lei LL; Zhao SM; Li RM; Dong X; Zhang XL; Zhou Y; Li SL; Cui YM
Front Pharmacol; 2023; 14():1132367. PubMed ID: 37188268
[No Abstract] [Full Text] [Related]
23. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
[TBL] [Abstract][Full Text] [Related]
24. Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study.
Oda K; Yamada T; Matsumoto K; Hanai Y; Ueda T; Samura M; Shigemi A; Jono H; Saito H; Kimura T
Clin Transl Sci; 2023 Nov; 16(11):2265-2275. PubMed ID: 37718491
[TBL] [Abstract][Full Text] [Related]
25. Dosing vancomycin in the super obese: less is more.
Crass RL; Dunn R; Hong J; Krop LC; Pai MP
J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
[TBL] [Abstract][Full Text] [Related]
26. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
27. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
[TBL] [Abstract][Full Text] [Related]
28. Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores.
Tsuda Y; Takahashi M; Watanabe F; Goto K; Echizen H
Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):647-655. PubMed ID: 37695498
[TBL] [Abstract][Full Text] [Related]
29. Model-Informed Precision Dosing of Vancomycin in Adult Patients Undergoing Hemodialysis.
Oda K; Jono H; Saito H
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0008923. PubMed ID: 37195225
[TBL] [Abstract][Full Text] [Related]
30. A Pharmacokinetic-Pharmacodynamic Analysis to Dose Optimize Daptomycin in Vancomycin-Resistant
Butterfield-Cowper JM
Ann Pharmacother; 2021 Jul; 55(7):846-855. PubMed ID: 33147997
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
[TBL] [Abstract][Full Text] [Related]
32. A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation.
Kim DJ; Lee DH; Ahn S; Jung J; Kiem S; Kim SW; Shin JG
J Clin Pharm Ther; 2019 Oct; 44(5):750-759. PubMed ID: 31228353
[TBL] [Abstract][Full Text] [Related]
33. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
34. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.
Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154
[TBL] [Abstract][Full Text] [Related]
35. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
36. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients.
Shoji K; Saito J; Nakagawa H; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Momper JD; Capparelli EV; Miyairi I
Microbiol Spectr; 2021 Oct; 9(2):e0046021. PubMed ID: 34612690
[TBL] [Abstract][Full Text] [Related]
37. Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling.
Alqahtani S; Almatrafi A; Bin Aydan N; Alqahtani M; Alzamil F; Alsultan A; Asiri Y
Pharmacotherapy; 2020 Dec; 40(12):1192-1200. PubMed ID: 33084059
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
[TBL] [Abstract][Full Text] [Related]
39. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children.
Lv CL; Lu JJ; Chen M; Zhang R; Li QC; Chen YY; Liu TT
J Clin Pharm Ther; 2020 Dec; 45(6):1278-1287. PubMed ID: 32557716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
